Delivery Order SPE2DX22D0089-SPE2D826F0C19
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a $44,104.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 1, 2025, with completion targeted for September 2, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be...
- The Defense Logistics Agency's Medical Supply Chain awarded a $27,653.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 5, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $27,272.80 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 2, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The company's place of performance...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed price delivery order valued at $15,886.02 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 16, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will...
- The Defense Logistics Agency Medical Supply Chain awarded a $46,078.10 firm fixed price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 7, 2025, with an ultimate completion date of October 8, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of performance is Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $210,271.14 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The delivery order will be performed at the vendor's Corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain has awarded a delivery order valued at $5,079.42 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999.999 billion through...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $316,010.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 6, 2025, with an ultimate completion date of October 7, 2025. This competitively awarded, non-set-aside contract is a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,343.54 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $56,274.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 17, 2025, with completion targeted for September 18, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made competitively and supports the...
- SPE2DX22D0089Indefinite Delivery Contract
- SPE2DX22D0089-SPE2D826F0C19Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $5,702.20 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 13, 2025, with an ultimate completion date of October 14, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 ceiling value through December 2026. The delivery order is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical pharmaceutical and medical supply needs for federal military and veteran healthcare systems through its comprehensive product portfolio. The company's federal contract awards demonstrate extensive capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a primary vendor under the DLA's Pharmaceutical Prime Vendor Global Program, AmerisourceBergen serves key federal customers including the Defense Health Agency and U.S. Coast Guard, leveraging its flexible contract vehicle to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 10/13/25 |